 |
6 Products |  |
1 Disease | | 6 Products |
|
4 Trials |  |
119 News |  |
| «123 |
- PBF-680 / Palobiofarma
Enrollment open: Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics (clinicaltrials.gov) - Dec 12, 2013
P2, N=18, Recruiting, Sponsor: Fundaci
Not yet recruiting --> Recruiting
- PBF-680 / Palobiofarma
Trial completion: "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers (clinicaltrials.gov) - Dec 12, 2013
P1, N=32, Completed, Sponsor: Fundaci
Not yet recruiting --> Recruiting Recruiting --> Completed
- PBF-680 / Palobiofarma
New P2 trial: Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics (clinicaltrials.gov) - Sep 9, 2013
P2, N=18, Recruiting, Sponsor: Fundaci
- PBF-680 / Palobiofarma
New P1 trial: "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers (clinicaltrials.gov) - May 1, 2013
P1, N=32, Completed, Sponsor: Fundaci
- taminadenant (NIR178) / Novartis
New P1 trial: Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers (clinicaltrials.gov) - Sep 23, 2012
P1, N=56, Completed, Sponsor: Fundaci